<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Takchi R</submitter><funding>U.S. Department of Defense</funding><funding>NCI NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | National Institutes of Health</funding><pagination>309</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11066049</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(5)</volume><pubmed_abstract>Sigma-2-ligands (S2L) are characterized by high binding affinities to their cognate sigma-2 receptor, overexpressed in rapidly proliferating tumor cells. As such, S2L were developed as imaging probes (ISO1) or as cancer therapeutics, alone (SV119 [C6], SW43 [C10]) and as delivery vehicles for cytotoxic drug cargoes (C6-Erastin, C10-SMAC). However, the exact mechanism of S2L-induced cytotoxicity remains to be fully elucidated. A series of high-affinity S2L were evaluated regarding their cytotoxicity profiles across cancer cell lines. While C6 and C10 displayed distinct cytotoxicities, C0 and ISO1 were essentially non-toxic. Confocal microscopy and lipidomics analysis in cellular and mouse models revealed that C10 induced increases in intralysosomal free cholesterol and in cholesterol esters</pubmed_abstract><journal>Cell death &amp; disease</journal><pubmed_title>Cytotoxic sigma-2 ligands trigger cancer cell death via cholesterol-induced-ER-stress.</pubmed_title><pmcid>PMC11066049</pmcid><funding_grant_id>R01 CA276378</funding_grant_id><funding_grant_id>R01 CA163764</funding_grant_id><funding_grant_id>W81XWH-17-1-0102</funding_grant_id><pubmed_authors>Takchi R</pubmed_authors><pubmed_authors>Hawkins WG</pubmed_authors><pubmed_authors>Gong Q</pubmed_authors><pubmed_authors>Prudner BC</pubmed_authors><pubmed_authors>Spitzer D</pubmed_authors><pubmed_authors>Hagi T</pubmed_authors><pubmed_authors>Van Tine BA</pubmed_authors><pubmed_authors>Jin LX</pubmed_authors><pubmed_authors>Newcomer KF</pubmed_authors><pubmed_authors>Vangveravong S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cytotoxic sigma-2 ligands trigger cancer cell death via cholesterol-induced-ER-stress.</name><description>Sigma-2-ligands (S2L) are characterized by high binding affinities to their cognate sigma-2 receptor, overexpressed in rapidly proliferating tumor cells. As such, S2L were developed as imaging probes (ISO1) or as cancer therapeutics, alone (SV119 [C6], SW43 [C10]) and as delivery vehicles for cytotoxic drug cargoes (C6-Erastin, C10-SMAC). However, the exact mechanism of S2L-induced cytotoxicity remains to be fully elucidated. A series of high-affinity S2L were evaluated regarding their cytotoxicity profiles across cancer cell lines. While C6 and C10 displayed distinct cytotoxicities, C0 and ISO1 were essentially non-toxic. Confocal microscopy and lipidomics analysis in cellular and mouse models revealed that C10 induced increases in intralysosomal free cholesterol and in cholesterol esters</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May</publication><modification>2026-06-03T03:53:10.968Z</modification><creation>2026-04-24T03:09:08.928Z</creation></dates><accession>S-EPMC11066049</accession><cross_references><pubmed>38697978</pubmed><doi>10.1038/s41419-024-06693-8</doi></cross_references></HashMap>